A unique finding of this study was an increased expression in BA patients of the cytoplasmic TUBA4A in cholangiocytes in comparison to the controls (Figure 6A), suggesting that increased cytoplasmic levels of TUBA4A in cholangiocytes correlate with poorer outcomes in BA patients. This evidence concerns the gene TUBA4A and breast angiosarcoma.